Iovance
Philadelphia, US · 1 known investors
Find your way into Iovance
Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.
Investors · 1
Founder mafia
2 people who came through Iovance went on to found or lead other companies.
In the news
Iovance Biotherapeutics (IOVA) Stock Could Be Rich Following Its 217% Run - Simply Wall St Newssimplywall.st · Aug 2026Frequently asked questions
- What does Iovance do?
- Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.
- Who are Iovance's investors?
- Iovance's investors include Avoro Capital Advisors.
- Where is Iovance headquartered?
- Iovance is headquartered in Philadelphia, US.